Hence, to investigate TP53 mutations in breast cancers with varying levels of p53, we next sequenced TP53 in a larger cohort of IDCs (n = 137), comprising 34 Grade 1, 34 Grade 2, and 69 Grade 3 cancers. This evidence concerns the gene TP53 and cancer.